John Valliant's Net Worth

John Valliant's net worth is estimated to be at least $517,191.81 as of 11/23/2024. CoreStreet's estimation of John Valliant's net worth is based on their sale of stock and current holding of stock.

John Valliant is CEO at Fusion Pharmaceuticals Inc. They have executed at least 20 trades of stock as per SEC Form 4 filings. Their most recent trade was for 4,511 units of FUSN stock on 04/27/2022. Their biggest sale was on 02/15/2022 when they sold 12,600 units of Fusion Pharmaceuticals Inc stock for $104,958.00. They typically trade 20 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $517,191.81
Most recent insider trade:
  • April 27, 2022

John Valliant's Insider Trading History

Fusion Pharmaceuticals IncTitleAmountPriceTypeTotal Value
April 27, 2022
CEO4,511$6.03Sell$27,201.33
April 25, 2022
CEO2,036$6.03Sell$12,277.08
April 20, 2022
CEO367$6.02Sell$2,209.34
April 13, 2022
CEO11,994$6.41Sell$76,881.54
April 11, 2022
CEO2,600$7.37Sell$19,162.00
April 8, 2022
CEO826$7.52Sell$6,211.52
April 6, 2022
CEO100$7.58Sell$758.00
March 30, 2022
CEO300$7.52Sell$2,256.00
March 28, 2022
CEO9,600$7.55Sell$72,480.00
March 25, 2022
CEO500$7.42Sell$3,710.00
March 23, 2022
CEO100$7.50Sell$750.00
March 21, 2022
CEO1,500$7.47Sell$11,205.00
March 17, 2022
CEO900$7.51Sell$6,759.00
March 7, 2022
CEO3,100$6.99Sell$21,669.00
March 4, 2022
CEO8,400$7.32Sell$61,488.00
Feb. 28, 2022
CEO3,100$7.40Sell$22,940.00
Feb. 24, 2022
CEO2,500$7.41Sell$18,525.00
Feb. 22, 2022
CEO4,100$7.85Sell$32,185.00
Feb. 17, 2022
CEO1,700$7.98Sell$13,566.00
Feb. 15, 2022
CEO12,600$8.33Sell$104,958.00